Items where Division is "03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Cellular Immunotherapy (Läubli)"
Number of items at this level: 4. 2023Wieboldt, Ronja. Interaction of sialylated glycans with Siglec receptors on suppressive myeloid cells. 2023, Doctoral Thesis, University of Basel, Faculty of Science. 2022Kirchhammer, Nicole and Trefny, Marcel P. and Natoli, Marina and Brücher, Dominik and Smith, Sheena N. and Werner, Franziska and Koch, Victoria and Schreiner, David and Bartoszek, Ewelina and Buchi, Mélanie and Schmid, Markus and Breu, Daniel and Hartmann, K. Patricia and Zaytseva, Polina and Thommen, Daniela S. and Läubli, Heinz and Böttcher, Jan P. and Stanczak, Michal A. and Kashyap, Abhishek S. and Plückthun, Andreas and Zippelius, Alfred. (2022) NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity. Science Translational Medicine, 14 (653). abm9043. 2021Wang, Jinyu. Sialoglycan – Siglec axis in the modulation of dendritic cells functions. 2021, Doctoral Thesis, University of Basel, Faculty of Science. 2020Trefny, Marcel P. and Kaiser, Monika and Stanczak, Michal A. and Herzig, Petra and Savic, Spasenija and Wiese, Mark and Lardinois, Didier and Läubli, Heinz and Uhlenbrock, Franziska and Zippelius, Alfred. (2020) PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade. Cancer immunology, immunotherapy : CII, 69 (8). pp. 1505-1517. |
